[go: up one dir, main page]

WO2008134578A3 - Synthèse d'inhibiteurs de transcriptase inverse radiomarqués actifs optiquement - Google Patents

Synthèse d'inhibiteurs de transcriptase inverse radiomarqués actifs optiquement Download PDF

Info

Publication number
WO2008134578A3
WO2008134578A3 PCT/US2008/061664 US2008061664W WO2008134578A3 WO 2008134578 A3 WO2008134578 A3 WO 2008134578A3 US 2008061664 W US2008061664 W US 2008061664W WO 2008134578 A3 WO2008134578 A3 WO 2008134578A3
Authority
WO
WIPO (PCT)
Prior art keywords
reverse transcriptase
transcriptase inhibitors
synthesis
optically active
active radio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2008/061664
Other languages
English (en)
Other versions
WO2008134578A2 (fr
Inventor
Dale O Kiesewetter
Mascio Michele Di
Esther Lim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of WO2008134578A2 publication Critical patent/WO2008134578A2/fr
Publication of WO2008134578A3 publication Critical patent/WO2008134578A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

L'invention concerne des inhibiteurs de transcriptase inverse marqués de manière isotope, y compris des composés selon la formule (I) dans laquelle R1 et R2 sont sélectionnés indépendamment parmi H, un groupe alkyle inférieur, aralkyle et acyle, et Z1 et Z2 forment indépendamment un phosphoester ou un phosphoamide. Des procédés pour synthétiser de tels composés sous des formes optiquement pures et racémiques sont également décrits. Des procédés d'utilisation des composés marqués, par exemple dans la surveillance par tomographie par émission de positons (PET), de l'activité rétrovirale sont également décrits.
PCT/US2008/061664 2007-04-28 2008-04-25 Synthèse d'inhibiteurs de transcriptase inverse radiomarqués actifs optiquement Ceased WO2008134578A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91473207P 2007-04-28 2007-04-28
US60/914,732 2007-04-28

Publications (2)

Publication Number Publication Date
WO2008134578A2 WO2008134578A2 (fr) 2008-11-06
WO2008134578A3 true WO2008134578A3 (fr) 2008-12-31

Family

ID=39577875

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2008/061664 Ceased WO2008134578A2 (fr) 2007-04-28 2008-04-25 Synthèse d'inhibiteurs de transcriptase inverse radiomarqués actifs optiquement

Country Status (1)

Country Link
WO (1) WO2008134578A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101928302B (zh) * 2010-04-29 2012-09-12 浙江康多利药业有限公司 N-苄基-9-[2-(二烷基磷酰基甲氧基)烷基]腺嘌呤及其制备方法和应用
CN102885846B (zh) * 2011-07-18 2014-02-19 中国医学科学院医药生物技术研究所 2-硫代-6-氮杂尿苷在制备抗hiv-1病毒的药物中的应用
EP3578563B1 (fr) 2011-12-22 2021-04-14 Geron Corporation Analogues de guanine en tant que substrats de télomérase et d'agents affecteurs de longueur de télomère
CN103665043B (zh) 2012-08-30 2017-11-10 江苏豪森药业集团有限公司 一种替诺福韦前药及其在医药上的应用
EP3714907A1 (fr) * 2019-03-29 2020-09-30 Santopietro, Riccardo Protocoles d'élution et dosages pour système d'élution radiopharmaceutique
KR20230013013A (ko) * 2019-09-20 2023-01-26 애보트 라피드 다이어그노스틱스 인터내셔널 언리미티드 컴퍼니 테노포비르 및 그의 유도체에 대해 지시된 항체
CN118652277A (zh) * 2024-08-19 2024-09-17 成都工业学院 一种用于治疗癌症疾病的化合物的制备方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KIESEWETTER ET AL: "Enantiomeric radiochemical synthesis of R and S (1-(6-amino-9H-purin-9-yl)-3-fluoropropan-2-yloxy)methylphosphonic acid (FPMPA)", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS, vol. 51, 13 March 2008 (2008-03-13), pages 187 - 194, XP002487665 *
KIESEWETTER ET AL: "Labelling methods and radiosynthesis-Organic positron emitters; (P053) R AND S [18F]FPMPA: NUCLEOTIDE ANALOGUE REVERSE TRANSCRIPTASE INHIBITOR FOR BIODISTRIBUTION STUDIES", JOURNAL OF LABELLED COMPOUNDS AND RADIOPHARMACEUTICALS SUPPLEMENT: 17TH INTERNATIONAL SYMPOSIUM ON RADIOPHARMACEUTICAL SCIENCES, vol. 50, no. S1, 11 April 2007 (2007-04-11), XP002487635 *

Also Published As

Publication number Publication date
WO2008134578A2 (fr) 2008-11-06

Similar Documents

Publication Publication Date Title
WO2008134578A3 (fr) Synthèse d'inhibiteurs de transcriptase inverse radiomarqués actifs optiquement
WO2009095872A3 (fr) Analogues marqués d'halogéno-benzamides en tant que produits radiopharmaceutiques multimodaux et leurs précurseurs
UA107175C2 (uk) Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
AR065280A1 (es) Agentes antiparasitarios
TW200728307A (en) Novel spirochromanone derivatives
MX2008000255A (es) Activadores de urea glucocinasa.
NZ600210A (en) Substituted 4-aminocyclohexane derivatives
PL3239145T3 (pl) Pochodne 1-[2-[3,5-podstawionego-1h-pirazol-1-ylo]acetylo]-4-piperydyno-karbonitrylu i -karbotiamidu jako związki pośrednie do wytwarzania fungicydów do ochrony roślin uprawnych
MX2009007713A (es) Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MX2009003739A (es) Derivados de hidrobenzamida como inhibidores de hsp90.
MX2010004232A (es) Compuesto de indolina de pirimidilo.
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
TW200637810A (en) Substituted N-aminomethylenesulfonamides, their preparation and use as medicaments
AR074545A1 (es) Proceso de preparacion de dihidroetorfina
DE50113943D1 (de) 4-alkoxy-cyclohexan-1-amino-carbonsäureester und verfahren zu ihrer herstellung
EA200500240A1 (ru) Новый способ синтеза соединений 1,3,4,5-тетрагидро-2h-3-бензазепин-2-она и применение при синтезе ивабрадина и его солей присоединения с фармацевтически приемлемой кислотой
PL1888514T3 (pl) Sole podstawionych estrów kwasu alofanowego i ich zastosowanie w środkach leczniczych
TW200738697A (en) Benzimidazole derivatives as 5-HT6,5-HT24
WO2007123942A3 (fr) Derives de benzodioxane et de benzodioxolane et leurs utilisations
MY141223A (en) Process for the preparation of 1,3-dihydro-2h-3-benzazepin-2-one and application to the preparation of ivabradine and their pharmaceutically acceptable salts
DK1869032T3 (da) Pyrimidindervater til anvendelse som anticancermidler
ATE471312T1 (de) Diaryltriazolmethylamin-derivate sowie ihre herstellung und therapeutische verwendung
DE60329721D1 (de) Regiospezifische synthese von nikotinderivaten
WO2007030848A3 (fr) Catabolites de chlorophylle non fluorescentes

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08746966

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08746966

Country of ref document: EP

Kind code of ref document: A2